{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T07:22:57Z","timestamp":1768807377606,"version":"3.49.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T00:00:00Z","timestamp":1726790400000},"content-version":"vor","delay-in-days":720,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Prevention of Alzheimer's Disease"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.14283\/jpad.2022.55","type":"journal-article","created":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T08:11:36Z","timestamp":1653466296000},"page":"646-654","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Intervention for Cognitive Reserve Enhancement in Delaying the Onset of Alzheimer's Symptomatic Expression (INCREASE) Study: Results from a Randomized Controlled Study of Medication Therapy Management Targeting a Delay in Prodromal Dementia Symptom Progression"],"prefix":"10.1016","volume":"9","author":[{"given":"Daniela C.","family":"Moga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.L.","family":"Abner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.A.","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Eckmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Huffmyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.I.","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.F.","family":"Beech","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"George","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.H.","family":"El Khouli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.A.","family":"Jicha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.14283\/jpad.2022.55_bib1","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0140-6736(20)30367-6","article-title":"Dementia prevention, intervention, and care: 2020 report of the Lancet Commission","volume":"396","author":"Livingston","year":"2020","journal-title":"Lancet"},{"key":"10.14283\/jpad.2022.55_bib2","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","article-title":"Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimer's & dementia: the journal of the Alzheimer's Association"},{"key":"10.14283\/jpad.2022.55_bib3","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3233\/JAD-2010-1237","article-title":"Conceptual evolution in Alzheimer's disease: implications for understanding the clinical phenotype of progressive neurodegenerative disease","volume":"19","author":"Jicha","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.14283\/jpad.2022.55_bib4","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S1474-4422(12)70191-6","article-title":"Cognitive reserve in ageing and Alzheimer's disease","volume":"11","author":"Stern","year":"2012","journal-title":"Lancet Neurol"},{"key":"10.14283\/jpad.2022.55_bib5","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1093\/gerona\/glv013","article-title":"Polypharmacy Among Adults Aged 65 Years and Older in the United States: 1988\u20132010","volume":"70","author":"Charlesworth","year":"2015","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.14283\/jpad.2022.55_bib6","first-page":"168","article-title":"Drug-related problems in the frail elderly","volume":"57","author":"Farrell","year":"2011","journal-title":"Canadian family physician Medecin de famille canadien"},{"key":"10.14283\/jpad.2022.55_bib7","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/WAD.0b013e31819d6ec9","article-title":"Polypharmacy and potentially inappropriate medication use among community-dwelling elders with dementia","volume":"24","author":"Lau","year":"2010","journal-title":"Alzheimer disease and associated disorders"},{"key":"10.14283\/jpad.2022.55_bib8","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13195-017-0263-9","article-title":"Optimizing medication appropriateness in older adults: a randomized clinical interventional trial to decrease anticholinergic burden","volume":"9","author":"Moga","year":"2017","journal-title":"Alzheimers Res Ther"},{"key":"10.14283\/jpad.2022.55_bib9","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.amjopharm.2007.12.009","article-title":"Polypharmacy and the balance of medication benefits and risks","volume":"5","author":"Steinman","year":"2007","journal-title":"The American journal of geriatric pharmacotherapy"},{"key":"10.14283\/jpad.2022.55_bib10","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/JGP.0b013e31802dd354","article-title":"Concomitant use of medications with anticholinergic properties and acetylcholinesterase inhibitors: impact on cognitive and physical functioning in Alzheimer disease","volume":"15","author":"Bottiggi","year":"2007","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.14283\/jpad.2022.55_bib11","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/jgs.15767","article-title":"American Geriatrics Society 2019 Updated AGS Beers Criteria(R) for Potentially Inappropriate Medication Use in Older Adults","volume":"67","author":"American Geriatrics Society Beers Criteria Update Expert P","year":"2019","journal-title":"J Am Geriatr Soc"},{"key":"10.14283\/jpad.2022.55_bib12","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1097\/01.JGP.0000224619.87681.71","article-title":"Long-term cognitive impact of anticholinergic medications in older adults","volume":"14","author":"Bottiggi","year":"2006","journal-title":"Am J Geriatr Psychiatry"},{"issue":"Suppl 1","key":"10.14283\/jpad.2022.55_bib13","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.neurobiolaging.2005.09.009","article-title":"Fitness, aging and neurocognitive function","volume":"26","author":"Kramer","year":"2005","journal-title":"Neurobiol Aging"},{"key":"10.14283\/jpad.2022.55_bib14","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1001\/jama.2010.2008","article-title":"Use of florbetapir-PET for imaging beta-amyloid pathology","volume":"305","author":"Clark","year":"2011","journal-title":"JAMA"},{"key":"10.14283\/jpad.2022.55_bib15","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1212\/WNL.0b013e3182661f74","article-title":"Amyloid-beta assessed by florbetapir F 18 PET and 18-month cognitive decline: a multicenter study","volume":"79","author":"Doraiswamy","year":"2012","journal-title":"Neurology"},{"key":"10.14283\/jpad.2022.55_bib16","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1001\/archneurol.2011.150","article-title":"Using positron emission tomography and florbetapir F18 to image cortical amyloid in patients with mild cognitive impairment or dementia due to Alzheimer disease","volume":"68","author":"Fleisher","year":"2011","journal-title":"Arch Neurol"},{"key":"10.14283\/jpad.2022.55_bib17","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.neuron.2014.10.038","article-title":"The evolution of preclinical Alzheimer's disease: implications for prevention trials","volume":"84","author":"Sperling","year":"2014","journal-title":"Neuron"},{"key":"10.14283\/jpad.2022.55_bib18","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1186\/s13063-019-3993-0","article-title":"INtervention for Cognitive Reserve Enhancement in delaying the onset of Alzheimer's Symptomatic Expression (INCREASE), a randomized controlled trial: rationale, study design, and protocol","volume":"20","author":"Moga","year":"2019","journal-title":"Trials"},{"key":"10.14283\/jpad.2022.55_bib19","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1001\/jamaneurol.2017.0892","article-title":"Association of Longitudinal Cognitive Decline With Amyloid Burden in Middle-aged and Older Adults: Evidence for a Dose-Response Relationship","volume":"74","author":"Farrell","year":"2017","journal-title":"JAMA Neurol"},{"key":"10.14283\/jpad.2022.55_bib20","doi-asserted-by":"crossref","first-page":"228fs213","DOI":"10.1126\/scitranslmed.3007941","article-title":"The A4 study: stopping AD before symptoms begin?","volume":"6","author":"Sperling","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.14283\/jpad.2022.55_bib21","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s40266-013-0118-4","article-title":"The medication appropriateness index at 20: where it started, where it has been, and where it may be going","volume":"30","author":"Hanlon","year":"2013","journal-title":"Drugs Aging"},{"key":"10.14283\/jpad.2022.55_bib22","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/WAD.0b013e318191c7dd","article-title":"The Alzheimer's Disease Centers' Uniform Data Set (UDS): the neuropsychologic test battery","volume":"23","author":"Weintraub","year":"2009","journal-title":"Alzheimer disease and associated disorders"},{"key":"10.14283\/jpad.2022.55_bib23","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/0895-4356(92)90144-C","article-title":"A method for assessing drug therapy appropriateness","volume":"45","author":"Hanlon","year":"1992","journal-title":"J Clin Epidemiol"},{"key":"10.14283\/jpad.2022.55_bib24","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jalz.2014.01.009","article-title":"Microdosing of scopolamine as a \u201ccognitive stress test\u201d: rationale and test of a very low dose in an at-risk cohort of older adults","volume":"10","author":"Snyder","year":"2014","journal-title":"Alzheimer's & dementia: the journal of the Alzheimer's Association"},{"key":"10.14283\/jpad.2022.55_bib25","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/hup.942","article-title":"The use of effect sizes to characterize the nature of cognitive change in psychopharmacological studies: an example with scopolamine","volume":"23","author":"Fredrickson","year":"2008","journal-title":"Hum Psychopharmacol"},{"key":"10.14283\/jpad.2022.55_bib26","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/jgs.13320","article-title":"Prevalence of potentially inappropriate medication use in older adults using the 2012 Beers criteria","volume":"63","author":"Davidoff","year":"2015","journal-title":"J Am Geriatr Soc"},{"key":"10.14283\/jpad.2022.55_bib27","doi-asserted-by":"crossref","DOI":"10.1111\/jgs.13701","article-title":"How to Use the American Geriatrics Society 2015 Beers Criteria-A Guide for Patients, Clinicians, Health Systems, and Payors","author":"Steinman","year":"2015","journal-title":"J Am Geriatr Soc"},{"key":"10.14283\/jpad.2022.55_bib28","doi-asserted-by":"crossref","DOI":"10.1111\/jgs.13702","article-title":"American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults","author":"By the American Geriatrics Society Beers Criteria Update Expert P","year":"2015","journal-title":"J Am Geriatr Soc"},{"key":"10.14283\/jpad.2022.55_bib29","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0002-9343(97)89519-8","article-title":"A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy","volume":"100","author":"Hanlon","year":"1996","journal-title":"Am J Med"},{"key":"10.14283\/jpad.2022.55_bib30","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.pec.2014.08.021","article-title":"Patient-centered interventions to improve medication management and adherence: a qualitative review of research findings","volume":"97","author":"Kuntz","year":"2014","journal-title":"Patient Educ Couns"},{"key":"10.14283\/jpad.2022.55_bib31","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/nur.10044","article-title":"Patient-centered interventions","volume":"25","author":"Lauver","year":"2002","journal-title":"Res Nurs Health"},{"key":"10.14283\/jpad.2022.55_bib32","doi-asserted-by":"crossref","DOI":"10.1111\/jgs.13807","article-title":"Alternative Medications for Medications in the Use of High-Risk Medications in the Elderly and Potentially Harmful Drug-Disease Interactions in the Elderly Quality Measures","author":"Hanlon","year":"2015","journal-title":"J Am Geriatr Soc"},{"key":"10.14283\/jpad.2022.55_bib33","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.neuropharm.2018.11.033","article-title":"Early memory consolidation window enables drug induced state-dependent memory","volume":"146","author":"Osorio-Gomez","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.14283\/jpad.2022.55_bib34","first-page":"1081","article-title":"State-dependent memory and its modulation by different brain areas and neurotransmitters","volume":"19","author":"Zarrindast","year":"2020","journal-title":"EXCLI J"},{"key":"10.14283\/jpad.2022.55_bib35","doi-asserted-by":"crossref","first-page":"754","DOI":"10.2174\/1389557519666191104110908","article-title":"Parkinson's Disease: A Review from Pathophysiology to Treatment","volume":"20","author":"Marino","year":"2020","journal-title":"Mini Rev Med Chem"},{"key":"10.14283\/jpad.2022.55_bib36","article-title":"Whitepaper: Defining and investigating cognitive reserve, brain reserve, and brain maintenance","author":"Stern","year":"2018","journal-title":"Alzheimer's & dementia: the journal of the Alzheimer's Association"}],"container-title":["The Journal of Prevention of Alzheimer's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580724002735?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580724002735?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T00:41:46Z","timestamp":1736469706000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2274580724002735"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S2274580724002735"],"URL":"https:\/\/doi.org\/10.14283\/jpad.2022.55","relation":{},"ISSN":["2274-5807"],"issn-type":[{"value":"2274-5807","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intervention for Cognitive Reserve Enhancement in Delaying the Onset of Alzheimer's Symptomatic Expression (INCREASE) Study: Results from a Randomized Controlled Study of Medication Therapy Management Targeting a Delay in Prodromal Dementia Symptom Progression","name":"articletitle","label":"Article Title"},{"value":"The Journal of Prevention of Alzheimer's Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.14283\/jpad.2022.55","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 THE AUTHORS. Published by Elsevier Masson SAS on behalf of SERDI Publisher. Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}